Canopy Growth Corp (CGC) stock
Close on Nov 12, 2026Market cap $242.74MP/E –Yield –
Canopy Growth Corp grew revenue 10.7% to C$308.32M over the twelve months to Sep 30, 2026. Free cash flow was -C$79.59M. At the latest close the market valued the company at C$342.41M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- C$342.41M
- P/E ratio
- –
- Price to sales
- 1.11
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -23.24%
Fundamentals
- Revenue
- C$308.32M
- Net income
- -C$268.34M
- EPS, diluted
- -0.70 CAD
- Free cash flow
- -C$79.59M
- Diluted shares
- 423M
Trading
- Next earnings
- Feb 5, 2027 (estimated, before the open)
- Previous close
- $0.60
- Open
- $0.59
- Day's range
- $0.56 – $0.60
- Volume
- 3,183,119
- Average volume (20 days)
- 2,565,539
- Beta (5 years)
- 1.88
- RSI (14 days)
- 29.5
- Volatility (1 year)
- 81.5%
- Relative volume
- 1.15×
- WACC
- 13.3%
Market cap history
Month-end market cap since 2017, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | CGC | S&P 500 | Difference | CGC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -24.3% | -2.7% | −21.6 pts | ||
| 3 months | -44.0% | -1.7% | −42.3 pts | ||
| Year to date | -49.7% | +11.9% | −61.6 pts | ||
| 1 year | -51.8% | +12.0% | −63.8 pts | ||
| 3 years | -89.0% | +78.2% | −167.2 pts | -52.1% | +21.2% |
| 5 years | -99.6% | +73.2% | −172.9 pts | -67.3% | +11.6% |
| 10 years | -99.2% | +309.6% | −408.8 pts | -38.1% | +15.1% |
Eleven years at a glance
Fiscal years 2016 to 2026 and trailing twelve months, CAD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Canopy Growth filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Update
- Update
- Results
About Canopy Growth
Medicinal Chemicals & Botanical Products
The company produces, distributes, and sells cannabis, hemp, and consumer goods. Its operations encompass adult-use cannabis, medical cannabis, and international cannabis markets, along with vaporizers and consumer wellness products under brands such as Storz & Bickel. The business operates across segments that include Canadian adult-use cannabis, Canadian medical cannabis, international cannabis markets, and consumer products. Its offerings include dried flower, extracts, and related vaporization equipment. The company serves medical patients seeking therapeutic cannabis solutions as well as adult recreational consumers through retail and wholesale distribution channels.
Company profile, executives and historyCanopy Growth stock: common questions
What is Canopy Growth's stock price?
CGC closed at $0.57 on Nov 12, 2026, down 5.16% on the day.
What is Canopy Growth's market cap?
Canopy Growth was worth $242.74M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is CGC's P/E ratio?
Canopy Growth lost money over the twelve months to Sep 30, 2026 (diluted EPS -0.70 CAD), so it has no meaningful P/E ratio.
How much revenue does Canopy Growth make?
Canopy Growth reported revenue of C$308.32M for the twelve months to Sep 30, 2026, up 10.7% from a year earlier.
Does Canopy Growth pay a dividend?
No. Canopy Growth has not paid a cash dividend over the last twelve months.
When does Canopy Growth report earnings next?
Canopy Growth is expected to report Q3 FY2027 results on Feb 5, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has CGC stock performed over the past year?
Including dividends, CGC returned -51.8% over the past year, against +12.0% for the S&P 500.
Who are Canopy Growth's competitors?
Companies most similar to Canopy Growth by business, industry and size include ACB, CRON, CRLBF, JUSH, GLAS.
See a number that looks wrong?